We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

136 hedge funds and large institutions have $604M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

77% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 35

50% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 18

7% more funds holding

Funds holding: 127 → 136 (+9)

5% more capital invested

Capital invested by funds: $576M → $604M (+$27.3M)

Holders
136
Holders Change
+9
Holders Change %
+7.09%
% of All Funds
3.66%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
27
Increased
62
Reduced
35
Closed
18
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
+$9K

Top Buyers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
+$21.9M
2
PCM
Penn Capital Management
Pennsylvania
+$9.28M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.87M
4
SFM
Soros Fund Management
New York
+$5.55M
5
Franklin Resources
Franklin Resources
California
+$4.42M

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$41.4M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$16.9M
3
PAMU
Pictet Asset Management (UK)
United Kingdom
-$15.3M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$3.34M
5
BAMS
Bellevue Asset Management (Switzerland)
Switzerland
-$2.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
101
American International Group
New York
$383K -$18.3K -762 -5%
DekaBank Deutsche Girozentrale
102
DekaBank Deutsche Girozentrale
Germany
$377K +$12K +500 +3%
NFA
103
Nationwide Fund Advisors
Ohio
$350K -$41.1K -1,715 -11%
CA
104
Commerzbank Aktiengesellschaft
Germany
$290K +$286K +11,945 New
Citigroup
105
Citigroup
New York
$271K +$43.7K +1,823 +20%
State Board of Administration of Florida Retirement System
106
State Board of Administration of Florida Retirement System
Florida
$256K +$4.34K +181 +2%
LSERS
107
Louisiana State Employees Retirement System
Louisiana
$246K +$4.79K +200 +2%
CCM
108
Catapult Capital Management
New York
$243K +$240K +10,000 New
Susquehanna International Group
109
Susquehanna International Group
Pennsylvania
$239K +$235K +9,813 New
Wells Fargo
110
Wells Fargo
California
$231K +$179K +7,460 +362%
Two Sigma Advisers
111
Two Sigma Advisers
New York
$224K +$221K +9,222 New
Thrivent Financial for Lutherans
112
Thrivent Financial for Lutherans
Minnesota
$218K -$999K -41,700 -82%
UBS AM
113
UBS AM
Illinois
$216K +$213K +8,900 New
OA
114
OFI Advisors
Pennsylvania
$174K +$31K +1,293 +22%
TRSOTSOK
115
Teachers Retirement System of the State of Kentucky
Kentucky
$117K – – –
MERSOM
116
Municipal Employees' Retirement System of Michigan
Michigan
$105K +$479 +20 +0.5%
PAM
117
Panagora Asset Management
Massachusetts
$94K – – –
MSA
118
Mason Street Advisors
Wisconsin
$77K +$3.33K +139 +5%
Legal & General Group
119
Legal & General Group
United Kingdom
$76K – – –
UBS Group
120
UBS Group
Switzerland
$64K +$54K +2,255 +564%
PI
121
PineBridge Investments
New York
$63K -$71.5K -2,983 -53%
PCM
122
Prelude Capital Management
New York
$61K +$59.9K +2,500 New
Victory Capital Management
123
Victory Capital Management
Texas
$51K +$50.4K +2,103 New
EWM
124
Evercore Wealth Management
New York
$49K – – –
BNP Paribas Financial Markets
125
BNP Paribas Financial Markets
France
$44.8K +$31.5K +1,316 +250%
3 4
5
6 7

SGNT Hedge Fund Activity: Q2 2015 in Review

136 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q2 2015, worth a combined $604M — up 4.7% from $576M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SGNT positions and 18 closed out — a net gain of 9 holders — while 62 added to existing stakes and 35 trimmed.

The largest buyer was HealthCor Management, opening a new position worth an estimated $21.9M. The largest seller was Morgan Stanley, cutting an estimated $41.4M.

  • 136 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q2 2015, up from 127 in Q1 2015.
  • Funds reported $604M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q2 2015, up 4.7% quarter-over-quarter.
  • 27 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q2 2015 and 18 closed out, a net change of +9 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2015 was HealthCor Management, an estimated $21.9M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q2 2015 was Morgan Stanley, an estimated $41.4M sold.

Based on aggregated 13F filings for Q2 2015.